Does PEBA Cover Weight Loss Medication? GLP-1 Exclusion and Appeals

PEBA does not cover weight loss medication. The South Carolina Public Employee Benefit Authority’s State Health Plan lists weight loss prescriptions as an excluded service, and anti-obesity drugs like Wegovy and Zepbound are not covered even when prescribed for obesity. GLP-1 medications such as Ozempic and Mounjaro are covered only when prescribed to manage Type 2 diabetes.1PEBA. 2026 Insurance Benefits Guide

What the Exclusion Actually Covers

The State Health Plan covers more than 540,000 public employees, retirees, spouses, and dependents, and it treats weight loss as a blanket exclusion. The 2026 Insurance Benefits Guide lists “weight loss prescriptions” among the services the plan does not cover.1PEBA. 2026 Insurance Benefits Guide Bariatric surgery is excluded too. The plan’s Summary of Benefits and Coverage states that bariatric surgery and weight loss are services the plan “generally does NOT cover.”2PEBA. Standard Plan Summary of Benefits and Coverage

Ozempic (semaglutide) and Mounjaro (tirzepatide) are covered exclusively for Type 2 diabetes. Neither drug is FDA-approved for weight loss on its own, and PEBA classifies any weight-loss-related use of these drugs as misuse and a plan exclusion.3PEBA. Health Care Policy Committee Materials, June 26, 2024

Why PEBA Turned Down Weight Loss Coverage

The PEBA Health Care Policy Committee looked at this directly in June 2024, reviewing a cost analysis of adding either drug or surgical coverage for weight loss. The committee concluded that neither produces a positive return on investment for the plan.3PEBA. Health Care Policy Committee Materials, June 26, 2024

Adding GLP-1 coverage for weight loss would have required a 9.8% increase in member contributions for 2025, roughly $311 million a year. Adding surgical weight loss coverage would have meant a 2.9% contribution increase, about $89 million a year. The analysis noted that GLP-1 medications would need to cost about 90% less than their current prices before the math changes, and that any savings from the drugs are not immediate.3PEBA. Health Care Policy Committee Materials, June 26, 2024

As of October 2025, the full PEBA board had not reversed the exclusion. Board materials describe anti-obesity medication coverage as “cost prohibitive,” though PEBA has committed to revisiting the analysis annually as prices and evidence change.4PEBA. Health Care Policy Committee Materials, October 2025

If You Take a GLP-1 for Diabetes

Diabetes coverage is intact, but the rules tightened. GLP-1 spending on Type 2 diabetes alone cost PEBA $106.4 million after rebates between January and September 2024,5SC Daily Gazette. States Consider High Costs, Possible Savings of Covering Weight Loss Drugs for Their Workers and the board approved two controls to curb what it called widespread misuse driven by social media:

  • GLP-1 prescriptions are limited to a 30-day supply per fill.
  • A prior authorization process requires members to document that their condition qualifies under the plan’s terms. It was fully phased in for commercial members by early 2025, with a more rigorous version added for Medicare members in July 2025.4PEBA. Health Care Policy Committee Materials, October 2025

The controls were projected to save about $18 million a year.6PEBA. Health Care Policy Committee Minutes, October 2024 By mid-2025, net GLP-1 spending for the commercial group was down 16% through June compared to the same period the previous year, while GLP-1 days of therapy in the unmanaged Medicare group grew by 23.5%.4PEBA. Health Care Policy Committee Materials, October 2025

Prescription benefits moved from Express Scripts to CVS Caremark effective January 1, 2026.7PEBA. New Pharmacy Benefits Manager You can verify whether a specific drug is covered or needs prior authorization by logging into your Caremark account or calling 833-291-3646.8PEBA. Prescription Benefits

Weight Management Programs Available at No Cost

The plan does offer several behavioral and lifestyle programs to members at no additional charge:

  • Wondr Health, a 12-week online behavioral weight management program with weekly video lessons and 42 weeks of follow-up support. Members, spouses, and dependent children 18 and older can enroll at wondrhealth.com/PEBA.9PEBA. Wondr Health
  • BlueCross Health Coaching, one-on-one coaching from a registered nurse.10PEBA. Weight Management
  • Weight Management for Kids and Teens, a confidential program for dependents ages 2 through 17.10PEBA. Weight Management
  • Virta, a diabetes care program using nutrition counseling and technology to help members reverse Type 2 diabetes through weight loss and blood sugar control.11BlueCross BlueShield of South Carolina. Diabetes Education
  • Personify Health, a digital platform for health assessments, fitness logging, and group challenges.10PEBA. Weight Management
  • Blue365, a discount program for fitness clubs, wearables, and nutrition programs.10PEBA. Weight Management

Appealing a Denied Prescription

If you believe a prescription claim was wrongly denied, prescription benefits are administered by Caremark as of January 2026, and the appeal starts there:

  • Contact Caremark to request a first reconsideration of the clinical denial.
  • If that does not resolve it, request a second reconsideration through Caremark.
  • If both reconsiderations fail, file a formal appeal with PEBA’s Insurance Appeals Division using Appeal Request Form 9201, along with the original denial letter and any supporting documentation.12PEBA. Appeal Request Form

Appeals go to IAD@peba.sc.gov or by mail to S.C. PEBA, Attn: Insurance Appeals Division, 202 Arbor Lake Drive, Columbia, SC 29223. Only the covered member or a legal representative may file. Providers and pharmaceutical manufacturers cannot act as the representative.12PEBA. Appeal Request Form

Could This Change?

PEBA has said it will reassess the cost-effectiveness analysis each year as pricing and data evolve.4PEBA. Health Care Policy Committee Materials, October 2025 The direction of travel elsewhere in South Carolina has been the other way, though. The state Medicaid program briefly covered GLP-1s for obesity starting November 1, 2024, but ended that coverage effective January 1, 2026, citing budget pressures and the federal government’s rejection of a proposed rule that would have required states to cover the drugs.13SC Daily Gazette. SC Medicaid Program To Stop Covering Expensive Weight Loss Drugs for Obesity Nationally, at least 15 states included anti-obesity drugs in their employee health plans as of 2025, while North Carolina, Ohio, and West Virginia ended that coverage.14National Conference of State Legislatures. GLP-1s: Cost, Coverage, State Policy Trends For now, if you are a PEBA member seeking a prescription to lose weight, the plan will not pay for it.